Common Stock, Shares, Outstanding of Cardiff Oncology, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cardiff Oncology, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Cardiff Oncology, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 68,305,000, a 2.7% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cardiff Oncology, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 68,305,000 +1,781,000 +2.7% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 67,095,000 +18,364,000 +38% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 66,526,000 +20,924,000 +46% 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q1 2025 66,526,000 +21,816,000 +49% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 66,524,000 +21,847,000 +49% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 48,731,000 +4,054,000 +9.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 45,602,000 +925,000 +2.1% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 44,710,000 +33,000 +0.07% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 44,677,000 0 0% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 44,677,000 +1,342,000 +3.1% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 44,677,000 +1,371,000 +3.2% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 44,677,000 +1,371,000 +3.2% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 44,677,000 +2,713,000 +6.5% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 43,335,000 +3,783,000 +9.6% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 43,306,000 +3,754,000 +9.5% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 43,306,000 +5,754,000 +15% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 41,964,000 +5,183,000 +14% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 39,552,000 +13,266,257 +50% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 39,552,000 +18,226,924 +85% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 37,552,000 +31,115,495 +483% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 36,781,000 +28,187,367 +328% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 26,285,743 +19,849,238 +308% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 21,325,076 +15,883,686 +292% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 6,436,505 +1,911,151 +42% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 8,593,633 +4,761,754 +124% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 6,436,505 -16,520,687 -72% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 5,441,390 -11,863,614 -69% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 4,525,354 -54,307,599 -92% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 3,831,879 +3,098,662 +423% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 22,957,192 -15,148,059 -40% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 17,305,004 -13,771,868 -44% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 58,832,953 +27,865,162 +90% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 733,217 -29,963,574 -98% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 38,105,251 +7,506,111 +25% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 31,076,872 +659,567 +2.2% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 30,967,791 +1,185,190 +4% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 30,696,791 +959,190 +3.2% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q3 2016 30,599,140 +876,538 +2.9% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 30,417,305 +5,544,703 +22% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 29,782,601 +5,475,310 +23% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 29,737,601 +10,821,808 +57% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 29,722,602 +10,819,819 +57% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 24,872,602 +5,969,820 +32% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 24,307,291 +5,404,509 +29% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 18,915,793 +13,011 +0.07% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 18,902,783 +10,834 +0.06% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 18,902,782 +3,173,258 +20% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 18,902,782 +3,386,591 +22% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 18,902,782 +3,424,605 +22% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 18,891,949 +4,711,223 +33% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 15,729,524 +1,554,464 +11% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 15,516,191 -51,630,666 -77% 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 15,478,177 +4,741,151 +44% 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q3 2012 14,180,726 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 14,175,060 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 67,146,857 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 10,737,026 31 Dec 2011 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.